{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/tuberculosis/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"b5294e44-2490-5ba7-8d81-0085ae3114a7","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 99af92e4-c35e-43df-8780-6e95e0a4928f --><h2>When should I suspect active tuberculosis?</h2><!-- end field 99af92e4-c35e-43df-8780-6e95e0a4928f -->","summary":"","htmlStringContent":"<!-- begin item 63e67a42-e7ff-47fd-ac6b-7e2e39a69260 --><!-- begin field f171ee63-70c1-4ac5-acd3-68a2c36b8763 --><p><strong>Be aware that the onset of active tuberculosis (TB) can be insidious, and early stages of the disease can be difficult to detect, leading to diagnostic delays or misdiagnosis.</strong></p><ul><li><strong>Suspect active TB in any person who is at <a class=\"topic-reference internal-reference\" href=\"/topics/tuberculosis/background-information/risk-factors/\">high risk</a> of developing TB <em>and </em>has general symptoms of weight loss, fever, night sweats, anorexia, or malaise.</strong><ul><li><strong>Consider pulmonary involvement </strong>if the person has a persistent productive cough, which may be associated with breathlessness and haemoptysis (usually late features), and <a class=\"topic-reference internal-reference\" href=\"/topics/tuberculosis/diagnosis/differential-diagnosis/\">alternative causes</a> have been excluded.</li><li><strong>Consider extrapulmonary involvement </strong>(especially in children, people from countries with a <a class=\"topic-reference internal-reference\" href=\"/topics/tuberculosis/background-information/risk-factors/\">high prevalence of TB</a>, and people with HIV), if they have organ-specific symptoms and signs, such as:<ul><li>Lymphadenopathy (typically painless lymph node swelling with a rubbery texture, often affecting the cervical or supraclavicular lymph node chains) — may suggest lymphatic TB.</li><li>Bone or joint pains, back pain, and joint swelling — may suggest joint or spinal TB.</li><li>Abdominal or pelvic pain, constipation, bowel obstruction — may suggest genitourinary or gastrointestinal TB.</li><li>Sterile pyuria — may suggest renal TB.</li><li>Headache, vomiting, irritability, confusion, cranial nerve abnormalities — may suggest TB meningitis. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/meningitis-bacterial-meningitis-meningococcal-disease/\">Meningitis - bacterial meningitis and meningococcal disease</a> for more information.</li><li>Skin lesions — for example, erythema nodosum (a hypersensitivity reaction triggered by TB infection); lupus vulgaris (painful nodular lesions affecting the face) may suggest cutaneous TB.</li><li>Breathlessness, chest pain, or ankle swelling — may suggest TB pericarditis.</li></ul></li></ul></li><li><strong>Be aware that children may present with non-specific symptoms and signs, </strong>such as poor weight gain, faltering growth, fatigue, or persistent fever. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/faltering-growth/\">Faltering growth</a> for more information.</li></ul><!-- end field f171ee63-70c1-4ac5-acd3-68a2c36b8763 --><!-- end item 63e67a42-e7ff-47fd-ac6b-7e2e39a69260 -->","topic":{"id":"c8d06469-2b39-5daa-bda8-b076b7204860","topicId":"c1897d19-8ea9-40e5-84a7-c45a80747a3e","topicName":"Tuberculosis","slug":"tuberculosis","lastRevised":"Last revised in January 2019","chapters":[{"id":"7216c242-e6e9-5726-9bad-d4bbd4071072","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aa25f749-53e8-5ff7-a3be-ddfd9f824295","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9c40ce5c-b940-5a6e-a414-cb379ae5f2c1","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5b948ae0-2789-5df7-b344-42eb6ae4054d","slug":"changes","fullItemName":"Changes"},{"id":"706989f4-45e1-583c-bcbc-d08833e25634","slug":"update","fullItemName":"Update"}]},{"id":"5edbfe3e-e825-5d79-a1d2-fa1b3b258467","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2e115c8b-8ca5-587b-bf34-83ddeeae2383","slug":"goals","fullItemName":"Goals"},{"id":"dbbfc2a1-e777-55e9-b654-44db5bf1efb4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bdce292e-6c5f-53df-a014-fc8432efa249","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"1f5efb77-1619-5cf3-be88-86fd03247324","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f93c9e3-2eb5-5d68-bbc0-99b7ea53b835","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"a028a0db-e900-5a0f-88ba-f333bcd824c9","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"24cda0d7-3e0d-58d5-9229-0a15e99013c4","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c26e051a-e3f8-57b8-95af-985e9e93a3aa","slug":"definition","fullItemName":"Definition"},{"id":"2deaf55e-4677-569a-a2e0-a8748b44829f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f2d695cb-4d0e-5513-a7f3-01df45726347","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"dc328fb0-65a2-5d6a-94fe-0bfa42962928","slug":"complications","fullItemName":"Complications"},{"id":"72382f51-4bac-5de9-9caf-c6f16082070d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"7e56c88f-1492-52ab-9f0b-cfc6b986db85","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b5294e44-2490-5ba7-8d81-0085ae3114a7","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"b90838b4-5d6d-57e8-aabd-afaad5a60e3f","slug":"investigations","fullItemName":"Investigations"},{"id":"8d7ee3e2-c863-574f-a042-172b8d909e84","slug":"screening","fullItemName":"Screening"},{"id":"a6c65c83-026b-50f1-b32d-5d28e8e7ae46","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"880c8c31-e325-5d4b-b4de-6ac05a1a9f94","fullItemName":"Management","slug":"management","subChapters":[{"id":"2ab22745-718a-5096-a75f-2e6c874d6267","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"fd726cd9-2566-5903-9e38-d7333b140c5a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3ac0b667-89b4-5934-98e1-938fd35e537f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a3834823-1bb2-52a0-92c5-cb04316db808","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b2e2271f-aaf8-57a5-aba4-42de8a475bc5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e611555b-70b5-5ea6-8e53-5220621e1603","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fdb64832-ab19-58f6-978e-d73fe8657b7d","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"200b04d2-7d10-5430-abe3-3802b135aea7","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"74113d46-a800-5f0b-9d3d-096dc4137936","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7e56c88f-1492-52ab-9f0b-cfc6b986db85","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"48bc2364-e23b-5f7e-98e3-fa8918e7ff70","slug":"basis-for-recommendation-3be","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field a6ee59cd-5de9-489b-93af-d392380f20e6 --><h3>Basis for recommendation</h3><!-- end field a6ee59cd-5de9-489b-93af-d392380f20e6 -->","summary":null,"htmlStringContent":"<!-- begin item 3be1c6bd-3f67-42c4-b733-84d514a74ea3 --><!-- begin field 3b7eeda2-ac64-443f-85ea-64725deefead --><p>The recommendations on when to suspect tuberculosis (TB) are largely based on the National Institute of Health and Care Excellence (NICE) clinical guideline <em>Tuberculosis. Prevention, diagnosis, management and service organisation</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">NICE, 2016</a>], the European Respiratory Society (ERS)/European Centre for Disease Prevention and Control (ECDC) Statement <em>European Union standards for tuberculosis care, 2017 update</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Migliori, 2018</a>], the British HIV Association (BHIVA) <em>Guidelines for the management of tuberculosis in adults living with HIV 2018</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Bracchi, 2018</a>], the Children's HIV Association (CHIVA) publication <em>HIV-Tuberculosis co-infection in children</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Whittaker, 2015</a>], a Public Health England (PHE) annual report [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>], expert opinion in review articles on pulmonary TB [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Campbell and Bah-Sow, 2006</a>] and on TB [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Hartman-Adams, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Dheda, 2016</a>], and expert opinion in the Oxford Textbook of Medicine [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Chaisson and Nachega, 2010</a>] and a dermatology textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Yates, 2010</a>].</p><h4>Pitfalls of TB diagnosis</h4><ul><li>The ERS/ECDC Statement on TB care highlights that TB is difficult to diagnose and may present with non-specific symptoms and signs, especially in immunocompromised people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Migliori, 2018</a>].<ul><li>This is supported by a small UK prospective cohort study (n = 175) investigating symptoms for diagnosing TB, which found that although weight loss, fever, and night sweats are common in active TB infection, in 25% of the study population these symptoms were absent [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Breen et al, 2008</a>].</li></ul></li><li>Expert opinion in a review article states that passive case finding (symptom-triggered testing in people presenting at healthcare facilities) fails to detect 40–50% of the total burden of disease. Classic presentation of active TB is less common in people with HIV [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Dheda, 2016</a>].</li><li>Delays in the diagnosis of TB are common, and most transmission of infection occurs between the onset of cough and the start of TB treatment. The PHE annual report notes that 31% of people with pulmonary TB experienced a delay of more than four months between symptom onset and treatment start. In 2017, delays were highest in people born in the UK (37%) and aged over 65 years (38%) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">PHE, 2018a</a>].<ul><li>Increased awareness of TB will promote early detection, which allows for the early initiation of treatment and, in theory, limits the spread of infection.</li></ul></li></ul><h4>When to consider pulmonary involvement</h4><ul><li>The ERS/ECDC Statement notes that the most common symptom of pulmonary TB is persistent cough with or without sputum production for more than 2–3 weeks, with haemoptysis being more unusual [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Migliori, 2018</a>].</li><li>The recommendations on when to consider pulmonary TB are supported by the CHIVA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Whittaker, 2015</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Hartman-Adams, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Dheda, 2016</a>].</li></ul><h4>When to consider extrapulmonary involvement</h4><ul><li>The information on the population groups at increased risk of extrapulmonary TB is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">NICE, 2016</a>], expert opinion in the CHIVA and BHIVA publications [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Whittaker, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Bracchi, 2018</a>], and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Hartman-Adams, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Dheda, 2016</a>].<ul><li>People with extrapulmonary disease are more likely to have a diagnostic delay compared with people with pulmonary TB, as extrapulmonary disease often has a more insidious onset with a wide range of vague and non-specific presenting symptoms and signs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">NICE, 2016</a>].</li><li>HIV infection increases the likelihood that latent TB infection will progress to active disease, and increases the likelihood of atypical manifestations, such as renal TB or TB meningitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Bracchi, 2018</a>].</li></ul></li></ul><h4>Non-specific symptoms and signs in children</h4><ul><li>The information that TB may present in children with faltering growth, or few or non-specific symptoms and signs, is based on the NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">NICE, 2016</a>] and expert opinion in the CHIVA publication [<a class=\"bibliography-reference internal-reference\" href=\"/topics/tuberculosis/references/\">Whittaker, 2015</a>].</li></ul><!-- end field 3b7eeda2-ac64-443f-85ea-64725deefead --><!-- end item 3be1c6bd-3f67-42c4-b733-84d514a74ea3 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}